Svenska
Boston
An independent LDT provider
Home
Press releases
Reports & Presentations
Stock information
Home
Stock information
Learn more
The Share
Stock information
The Share
Learn more
Share capital development
PDMR transactions
Ownership structure
Analysts
Governance
Home
Governance
Learn more
General meetings
Board of Directors
Management team
Governance report
Nomination committee
External auditors
Remuneration committee
Internal control
Articles of association
Sustainability Report
Rights issue 2023
Prospectuses
Home
Prospectuses
Learn more
Listing transfer (2018)
Rights Issue (2016)
Listing (2015)
Financial targets
Calendar
IR Contact
Home
IR Contact
Learn more
Subscribe
Subscribe
English
Svenska
NOTE:
Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:
https://rb.gy/09bxx
Press releases
Show
All
Regulatory
R = Regulatory
April 28, 2022
Immunovia Interim Report January-March 2022 Presentation
January 4, 2022
New Year Letter from Chairman Carl Borrebaeck to all shareholders
December 23, 2021
Year-end greeting from Patrik Dahlen, CEO Immunovia, to all...
November 16, 2021
Jefferies London Healthcare Conference
Home
Archives for brittlouise
